<DOC>
	<DOCNO>NCT01239849</DOCNO>
	<brief_summary>Because Diabetes Mellitus one major risk factor CV disease lot related evidence publish include CARDS study show definite benefit statin treatment DM patient influence ADA guideline . &amp; NCEP ATP III update . However , large unmet medical need DM patient n't reach target LDL-C level define NCEPT ATP III update physician usually start low dose statin titrate goal . Thus , curious change prescription pattern tailor way ; select start dose base individual risk factor concomitant status impact goal achieve rate DM patient . Besides , go find preliminary data marker change ; small dense LDL adiponectine ; . Small dense LDL-C inflammatory atherogenic LDL-C may explain impact triglyceride . Adiponectin another good marker relate obesity metabolic syndrome .</brief_summary>
	<brief_title>Korean AMADEUS Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Korean Diabetes Patients 2 . Is ≥ 18 ≤ 80 year olds 3 . Has diagnosis dyslipidemia 4 . Has 100 mg/dl ≤ LDL cholesterol ≤ 220 mg/dl 5 . Has triglyceride level ≤ 600 mg/dl 6 . Has HbA1c ≤ 12 % 7 . If female , postmenopausal , surgically sterilize , use reliable method birth control consider suitable investigator 8 . Can discontinue current antilipidemic medication 4 week washout period 9 . Has provide write informed consent prior initiation study procedure 1 . Is pregnant lactate 2 . Abuse alcohol and/or drug 3 . Uncontrolled diabetes ( HbA1c &gt; 12 % ) 4 . Has impair hepatic function , show limited alanine aminotransferase ( ALT , SGOT ) aspartate aminotransferase ( AST , SGOT ) ≥ 2times upper limit normal baseline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Diabetes Mellitus , Hypercholesterolemia</keyword>
</DOC>